Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Santiago Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Miguel Pavlovsky, Virginia Prates, Lucia Zoppegno, Ana Lisa Basquiera, Ider Cerutti, Andrea Rodriguez, Gustavo Milone, Vanesa Castano, Silvia Rudoy, Federico Sackmann, Lourdes Valles, Francisco Lastiri

Blood (2010) 116 (21): 1772.

https://doi.org/10.1182/blood.V116.21.1772.1772

Published: 2010

Journal Articles

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Astrid Pavlovsky, Santiago Pavlovsky, Isolda Fernandez, Lucia Zoppegno, Ider Cerutti, Miguel Arturo Pavlovsky, Virginia Prates, Ana Basquiera, Claudia Corrado, Gustavo Milone, Maria Cabrejo, Horacio Fernandez Grecco, Graciela Avila, Viviana Flores Dutrus, Karina Gumpel, Vanina Cabanne, Silvia Saba, Francisco Lastiri

Blood (2008) 112 (11): 2592.

https://doi.org/10.1182/blood.V112.11.2592.2592

Published: 2008

Journal Articles

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

Santiago Pavlovsky, Claudia Corrado, Miguel A Pavlovsky, Virginia Prates, Lucia Zoppegno, Mario Giunta, Ider Cerutti, Elsa Palomino, Graciela Avila, Francisco Lastiri

Blood (2008) 112 (11): 1454.

https://doi.org/10.1182/blood.V112.11.1454.1454

Published: 2008

Journal Articles

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Santiago Pavlovsky, MD, PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Virginia Prates, MD, Lucia Zoppegno, MD, Mario Giunta, MD, Ider Cerutti, MD, Elsa Palomino, MD, Fernando Pagani, MD, Francisco Lastiri, MD, Maria C. Narbaitz, MD, Fernando Cavagnaro, MD, Graciela Avila, MD

Blood (2006) 108 (11): 2474.

https://doi.org/10.1182/blood.V108.11.2474.2474

Published: 2006

Journal Articles

Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).

Jorge H. Milone, MD, Javier A. Bordone, MD, Gustavo Kusminsky, MD, Cecilia Foncuberta, MD, Juan Garcia, MD, Juliana Martinez Rolon, MD, Eduardo Bullorsky, MD, Cristina Dengra, MD, Ider Cerutti, MD

Blood (2005) 106 (11): 5425.

https://doi.org/10.1182/blood.V106.11.5425.5425

Published: 2005

Journal Articles

Rituximab - Inmunotherapy Combined with Chemotherapy, CHOP for the Treatment of Patients with Difusse Large B - Cell Lymphoma (DLBCL).

Jorge H. Milone, MD, Fernando Bezares, MD, Maria del Carmen Ardaiz, MD, Dardo Riveros, MD, Luis Palmer, MD, Ider Cerutti, MD, Alfredo Basso, MD, Marta Gelemur, MD, Carlos Cánepa, MD, Gustavo Kusminsky, MD, Marta Zerga, MD

Blood (2005) 106 (11): 4745.

https://doi.org/10.1182/blood.V106.11.4745.4745

Published: 2005

Journal Articles

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Santiago Pavlovsky, MD PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Mario Giunta, MD, Lucia Zoppegno, MD, Virginia Prates, MD, Francisco Lastiri, PhD, Ider Cerutti, MD, Maria C. Narbaitz, MD, Silvia Rudoy, MD, Fernando Cavagnaro, MD, Alejandra Kurchan, MD, Elsa Palomino, MD, Cesar Campo, MD

Blood (2004) 104 (11): 1310.

https://doi.org/10.1182/blood.V104.11.1310.1310

Published: 2004

NARROW

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).

Rituximab - Inmunotherapy Combined with Chemotherapy, CHOP for the Treatment of Patients with Difusse Large B - Cell Lymphoma (DLBCL).

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Email alerts

ASH Publications

American Society of Hematology

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).

Rituximab - Inmunotherapy Combined with Chemotherapy, CHOP for the Treatment of Patients with Difusse Large B - Cell Lymphoma (DLBCL).

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only